Exelixis (EXEL) Treasury Shares (2010 - 2026)
Exelixis (EXEL) recorded quarterly Treasury Shares of $13.7 million in Q2 2026, down 54.64% quarter-over-quarter from $30.2 million in Q1 2026, and down 3.52% on a YoY basis from $14.2 million in Q2 2025.
Exelixis (EXEL) Treasury Shares (2010 - 2026) Analysis & Trends
Exelixis' Treasury Shares history runs 17 years deep, the most recent figure standing at $13.7 million for Q2 2026.
- In Q2 2026, Treasury Shares fell 3.52% year-over-year to $13.7 million; the TTM figure through Apr 2026 stood at $13.7 million (down 3.52% YoY), while the FY2026 annual figure was $30.2 million, up 133.38% from the prior year.
- Treasury Shares was $13.7 million for Q2 2026 at Exelixis, down from $30.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $30.2 million in Q1 2026 to a low of $5.7 million in Q2 2022.
- Historically, Treasury Shares has averaged $15.7 million across 5 years, with a median of $13.7 million in 2026.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares jumped 207.2% in 2024, then tumbled 50.67% in 2025.
- A 5-year view of Treasury Shares shows it stood at $11.3 million in 2022, then jumped by 132.25% to $26.2 million in 2023, then declined by 20.77% to $20.8 million in 2024, then climbed by 15.96% to $24.1 million in 2025, then plunged by 43.15% to $13.7 million in 2026.
- The last three Treasury Shares figures came in at $13.7 million (Q2 2026), $30.2 million (Q1 2026), and $24.1 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 13.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 13.70 Mn |
| Apr 3, 2026 | 13.70 Mn |
| Jan 2, 2026 | 30.20 Mn |
| Jan 2, 2026 | 30.20 Mn |
| Oct 3, 2025 | 24.10 Mn |
| Oct 3, 2025 | 24.10 Mn |
| Jul 4, 2025 | 20.50 Mn |
| Jul 4, 2025 | 20.50 Mn |
| Apr 4, 2025 | 14.20 Mn |
| Apr 4, 2025 | 14.20 Mn |
| Jan 3, 2025 | 12.94 Mn |
| Jan 3, 2025 | 12.94 Mn |
| Sep 27, 2024 | 20.78 Mn |
| Sep 27, 2024 | 20.78 Mn |
| Jun 28, 2024 | 20.30 Mn |
| Jun 28, 2024 | 20.30 Mn |
| Mar 29, 2024 | 8.60 Mn |
| Mar 29, 2024 | 8.60 Mn |
| Dec 29, 2023 | 26.23 Mn |
| Dec 29, 2023 | 26.23 Mn |